Five days of oral topotecan (hycamtin®), a phase I and pharmacological study in adult patients with solid tumours

1998 ◽  
Vol 34 (7) ◽  
pp. 1030-1035 ◽  
Author(s):  
C.J.H Gerrits ◽  
H Burris ◽  
J.H.M Schellens ◽  
A.S.T Planting ◽  
M.E.L van den Burg ◽  
...  
Keyword(s):  
Phase I ◽  
Pharmacological Study ◽  
Solid Tumours ◽  
Adult Patients ◽  
Oral Topotecan

scholarly journals Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours

2015 ◽  
Vol 113 (5) ◽  
pp. 706-715 ◽  
Author(s):  
B Milojkovic Kerklaan ◽  
M P J Lolkema ◽  
L A Devriese ◽  
E E Voest ◽  
A Nol-Boekel ◽  
...  
Keyword(s):  
Phase I ◽  
Pharmacological Study ◽  
Solid Tumours ◽  
Oral Topotecan

Phase I and pharmacological study of oral topotecan and the BCRP and P-gp inhibitor elacridar

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2003-2003
Author(s):  
J. H. Schellens ◽  
I. E. Kuppens ◽  
R. C. Jewell ◽  
S. A. Radema ◽  
E. O. Witteveen ◽  
...  
Keyword(s):  
Phase I ◽  
Pharmacological Study ◽  
Oral Topotecan

scholarly journals Phase I and pharmacologic study of CT-2584 HMS, a modulator of phosphatidic acid, in adult patients with solid tumours

2000 ◽  
Vol 83 (12) ◽  
pp. 1599-1606
Author(s):  
S L Cheeseman ◽  
M Brannan ◽  
A McGown ◽  
P Khan ◽  
C Gardner ◽  
...  
Keyword(s):  
Phosphatidic Acid ◽  
Phase I ◽  
Solid Tumours ◽  
Adult Patients ◽  
Pharmacologic Study

Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours

2002 ◽  
Vol 38 (17) ◽  
pp. 2272-2278 ◽  
Author(s):  
A. Awada ◽  
F.A.L.M. Eskens ◽  
M. Piccart ◽  
D.L. Cutler ◽  
A. van der Gaast ◽  
...  
Keyword(s):  
Phase I ◽  
Pharmacological Study ◽  
Solid Tumours ◽  
Farnesyltransferase Inhibitor ◽  
Once Daily

scholarly journals Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study

2019 ◽  
Vol 30 (2) ◽  
pp. 325-331 ◽  
Author(s):  
D.S. Hong ◽  
T.M. Bauer ◽  
J.J. Lee ◽  
A. Dowlati ◽  
M.S. Brose ◽  
...  
Keyword(s):  
Phase I ◽  
Dose Escalation ◽  
Solid Tumours ◽  
Adult Patients ◽  
Open Label ◽  
Dose Escalation Study ◽  
Open Label Phase

Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours

2002 ◽  
Vol 38 (12) ◽  
pp. 1615-1621 ◽  
Author(s):  
M Crul ◽  
H Rosing ◽  
G.J de Klerk ◽  
R Dubbelman ◽  
M Traiser ◽  
...  
Keyword(s):  
Oral Administration ◽  
Phase I ◽  
Pharmacological Study ◽  
Solid Tumours ◽  
Daily Oral Administration

scholarly journals Phase I trial and pharmacological study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP study

2001 ◽  
Vol 84 (5) ◽  
pp. 604-610 ◽  
Author(s):  
F Doz ◽  
J C Gentet ◽  
F Pein ◽  
D Frappaz ◽  
P Chastagner ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Trial ◽  
Pharmacological Study ◽  
Solid Tumours

Phase I and pharmacological study of oral topotecan and the BCRP and P-gp inhibitor elacridar

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2003-2003 ◽  
Author(s):  
J. H. Schellens ◽  
I. E. Kuppens ◽  
R. C. Jewell ◽  
S. A. Radema ◽  
E. O. Witteveen ◽  
...  
Keyword(s):  
Phase I ◽  
Pharmacological Study ◽  
Oral Topotecan
Sign in / Sign up

Export Citation Format

Share Document